Oxybutynin Chloride Tablet
Product Images NDC 60687-899

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 60687-899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5mg Oxybutynin Chloride Tablet Blister.jpg (5mg Oxybutynin Chloride Tablet Blister)

5mg Oxybutynin Chloride Tablet Blister.jpg (5mg Oxybutynin Chloride Tablet Blister)
Labels for Oxybutynin Chloride 5 mg oral tablets by American Health Packaging. Each label features the product name, strength, barcode, lot number, expiration date, and labeler information repeated multiple times in a grid format on a single sheet.*
FDA Label Image

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 01)

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 01)
Chemical structure diagram of Oxybutynin Chloride, showing its molecular composition including a cyclohexyl group, a phenyl ring, hydroxyl and carbonyl groups, and an ethyl-substituted nitrogen with a chloride ion.*
FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 02)

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 02)
A line graph showing mean plasma R-oxybutynin concentration (ng/mL) over a 24-hour period for oxybutynin 5 mg administered three times daily (TID). The x-axis represents time in hours, while the y-axis represents mean plasma concentration. The data points include error bars indicating variability at each time point.*
FDA Label Image

Oxy 3 (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 03)

Oxy 3 (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 03)
A line graph depicting mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The vertical axis shows concentration values from 0 to 10 ng/mL, while the horizontal axis shows time points from 0 to 12 hours. Data points show a peak concentration around 1 hour, followed by a decline to near baseline by 12 hours, with error bars indicating variability at each time point.*
FDA Label Image

T:\regulatory\fda Submissions\ahp Regulatory Submissions\oxybutynin Chloride\strides\2026-03-24_60687-899-01_new\supporting Materials\5mg Oxybutynin Chloride Tablets Carton.jpg (Image 01)

T:\regulatory\fda Submissions\ahp Regulatory Submissions\oxybutynin Chloride\strides\2026-03-24_60687-899-01_new\supporting Materials\5mg Oxybutynin Chloride Tablets Carton.jpg (Image 01)
Label for Oxybutynin Chloride Tablets USP 5 mg by American Health Packaging. The label displays the NDC 60687-899-01 and indicates the package contains 100 oral tablets (10x10) for prescription use. It includes a barcode, storage instructions, and a QR code for current prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.